Tech Company Financing Transactions

Micrus Endovascular Funding Round

Micrus Endovascular closed a $12.1 million funding round on 3/31/2007. Investors included private investors.

Transaction Overview

Announced On
3/31/2007
Transaction Type
Venture Equity
Amount
$12,090,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Acquired or Merged
Industry
Medical Devices & Instruments
Mailing Address
821 Fox Lane
San Jose, CA 95131
USA
Email Address
Overview
Micrus Endovascular manufactures and markets both implantable and disposable medical devices used in the treatment of cerebral vascular diseases. Our products are used by interventional neuroradiologists and neurosurgeons primarily to treat cerebral aneurysms in the brain responsible for hemorrhagic stroke, a significant cause of death in the United States.
Profile
Micrus Endovascular LinkedIn Company Profile
Social Media
Micrus Endovascular Company Twitter Account
Company News
Micrus Endovascular News
Facebook
Micrus Endovascular on Facebook
YouTube
Micrus Endovascular on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
John Kilcoyne
  John Kilcoyne LinkedIn Profile  John Kilcoyne Twitter Account  John Kilcoyne News  John Kilcoyne on Facebook
Chief Financial Officer
Gordon Sangster
  Gordon Sangster LinkedIn Profile  Gordon Sangster Twitter Account  Gordon Sangster News  Gordon Sangster on Facebook
Chief Operating Officer
Robert Stern
  Robert Stern LinkedIn Profile  Robert Stern Twitter Account  Robert Stern News  Robert Stern on Facebook
VP - Finance
Jim Robbins
  Jim Robbins LinkedIn Profile  Jim Robbins Twitter Account  Jim Robbins News  Jim Robbins on Facebook
VP - General Counsel
Carolyn Bruguera
  Carolyn Bruguera LinkedIn Profile  Carolyn Bruguera Twitter Account  Carolyn Bruguera News  Carolyn Bruguera on Facebook
VP - Human Resources
Richard Snyder
  Richard Snyder LinkedIn Profile  Richard Snyder Twitter Account  Richard Snyder News  Richard Snyder on Facebook
VP - Marketing
Robert Colloton
  Robert Colloton LinkedIn Profile  Robert Colloton Twitter Account  Robert Colloton News  Robert Colloton on Facebook
VP - Operations
Edward Ruppel
  Edward Ruppel LinkedIn Profile  Edward Ruppel Twitter Account  Edward Ruppel News  Edward Ruppel on Facebook
VP - R & D
David Watson
  David Watson LinkedIn Profile  David Watson Twitter Account  David Watson News  David Watson on Facebook
VP - Regulatory Affairs
Mike Crompton
  Mike Crompton LinkedIn Profile  Mike Crompton Twitter Account  Mike Crompton News  Mike Crompton on Facebook
VP - Sales
William Rigas
  William Rigas LinkedIn Profile  William Rigas Twitter Account  William Rigas News  William Rigas on Facebook


 

 

Browse more venture capital transactions:

Prev: 3/31/2007: Synapse Biomedical venture capital transaction
Next: 3/31/2007: Compliance 360 venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to record tech company VC transactions. VC investment data records reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary